Cargando…
Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients. Methods: Clinical data from 253 patien...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666181/ https://www.ncbi.nlm.nih.gov/pubmed/38028594 http://dx.doi.org/10.3389/fgene.2023.1271710 |
_version_ | 1785138985200254976 |
---|---|
author | Liu, Yinfeng Zheng, Jie Xu, Yue Lv, Ji Wu, Zizheng Feng, Kai Liu, Jiani Yan, Weitao Wei, Liguang Zhao, Jiangman Jiang, Lisha Han, Meng |
author_facet | Liu, Yinfeng Zheng, Jie Xu, Yue Lv, Ji Wu, Zizheng Feng, Kai Liu, Jiani Yan, Weitao Wei, Liguang Zhao, Jiangman Jiang, Lisha Han, Meng |
author_sort | Liu, Yinfeng |
collection | PubMed |
description | Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients. Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants’ impact on protein structure and function. Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 (15.6%), and BRCA2 (15.0%). ACMG classification identified 7% of patients harboring Pathogenic/Likely Pathogenic (P/LP) variants, with one case displaying a pathogenic BRCA1 mutation linked to triple-negative breast cancer (TNBC). Also identified were two pathogenic MUTYH variants, previously associated with colon cancer but increasingly implicated in breast cancer. Variants of uncertain significance (VUS) were identified in 112 patients, with PTEN c.C804A showing the highest frequency. The role of these variants in sporadic breast cancer oncogenesis was suggested. In-depth exploration of previously unreported variants led to the identification of three potential pathogenic variants: ATM c.C8573T, MSH3 c.A2723T, and CDKN1C c.C221T. Their predicted impact on protein structure and stability suggests a functional role in cancer development. Conclusion: This study reveals a comprehensive overview of the genetic variants landscape in Chinese breast cancer patients, highlighting the prevalence and potential implications of rare variants. We emphasize the value of comprehensive genomic profiling in breast cancer management and the necessity of continuous research into understanding the functional impacts of these variants. |
format | Online Article Text |
id | pubmed-10666181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106661812023-11-09 Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China Liu, Yinfeng Zheng, Jie Xu, Yue Lv, Ji Wu, Zizheng Feng, Kai Liu, Jiani Yan, Weitao Wei, Liguang Zhao, Jiangman Jiang, Lisha Han, Meng Front Genet Genetics Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients. Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants’ impact on protein structure and function. Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 (15.6%), and BRCA2 (15.0%). ACMG classification identified 7% of patients harboring Pathogenic/Likely Pathogenic (P/LP) variants, with one case displaying a pathogenic BRCA1 mutation linked to triple-negative breast cancer (TNBC). Also identified were two pathogenic MUTYH variants, previously associated with colon cancer but increasingly implicated in breast cancer. Variants of uncertain significance (VUS) were identified in 112 patients, with PTEN c.C804A showing the highest frequency. The role of these variants in sporadic breast cancer oncogenesis was suggested. In-depth exploration of previously unreported variants led to the identification of three potential pathogenic variants: ATM c.C8573T, MSH3 c.A2723T, and CDKN1C c.C221T. Their predicted impact on protein structure and stability suggests a functional role in cancer development. Conclusion: This study reveals a comprehensive overview of the genetic variants landscape in Chinese breast cancer patients, highlighting the prevalence and potential implications of rare variants. We emphasize the value of comprehensive genomic profiling in breast cancer management and the necessity of continuous research into understanding the functional impacts of these variants. Frontiers Media S.A. 2023-11-09 /pmc/articles/PMC10666181/ /pubmed/38028594 http://dx.doi.org/10.3389/fgene.2023.1271710 Text en Copyright © 2023 Liu, Zheng, Xu, Lv, Wu, Feng, Liu, Yan, Wei, Zhao, Jiang and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Liu, Yinfeng Zheng, Jie Xu, Yue Lv, Ji Wu, Zizheng Feng, Kai Liu, Jiani Yan, Weitao Wei, Liguang Zhao, Jiangman Jiang, Lisha Han, Meng Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China |
title | Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China |
title_full | Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China |
title_fullStr | Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China |
title_full_unstemmed | Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China |
title_short | Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China |
title_sort | multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern china |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666181/ https://www.ncbi.nlm.nih.gov/pubmed/38028594 http://dx.doi.org/10.3389/fgene.2023.1271710 |
work_keys_str_mv | AT liuyinfeng multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT zhengjie multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT xuyue multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT lvji multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT wuzizheng multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT fengkai multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT liujiani multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT yanweitao multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT weiliguang multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT zhaojiangman multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT jianglisha multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina AT hanmeng multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina |